Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
PML risk stratification using anti-JCV antibody index and L-selectin.
[Charcot and his legacy to medicine].
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature.
Therapeutic decision making in a new drug era in multiple sclerosis.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
Passive induction of experimental allergic encephalomyelitis.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
Vitamin D in health and disease: a literature review.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
The induction of Treg cells by gut-indigenous Clostridium.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study.
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.
GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Iron in multiple sclerosis: roles in neurodegeneration and repair.
Assessment of visual disability using visual evoked potentials.
Pages
« first
‹ previous
…
214
215
216
217
218
219
220
221
222
…
next ›
last »